Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Verrica Pharmaceuticals sell BiotechBee

Start price
€4.63
10:42 / 60%
Target price
€3.00
29.03.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 29.03.26. The prediction end date can be changed by BiotechBee at any time.
Performance without dividends (%)
Name 1w
Verrica Pharmaceuticals -
iShares Core DAX® 0.393%
iShares Nasdaq 100 0.394%
iShares Nikkei 225® 1.038%
iShares S&P 500 -0.046%

According to BiotechBee what are the pros and cons of Verrica Pharmaceuticals for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Verrica Pharmaceuticals diskutieren
Prediction Sell
Perf. (%) -
Target price 3.000
Change
Ends at 29.03.26

Sell mit Kursziel 3,0